Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95)

被引:295
作者
Zouboulis, CC
Seltmann, H
Neitzel, H
Orfanos, CE
机构
[1] Free Univ Berlin, Univ Med Ctr Benjamin Franklin, Dept Dermatol, D-12200 Berlin, Germany
[2] Humboldt Univ, Virchow Clin, Inst Human Genet, Berlin, Germany
关键词
androgens; cell transformation; viral antigens; polyomavirus transforming; retinoids;
D O I
10.1046/j.1523-1747.1999.00771.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Human facial sebaceous gland cells were transfected with a PBR-322-based plasmid containing the coding region for the Simian virus-40 large T antigen, The resulting proliferating cell cultures have been passaged over 50 times to date, have been cloned, and show no signs of senescence after 4 1/2 y in vitro, whereas normal human sebocytes can only be grown for three to six passages, The immortalized transfected cells, termed SZ95, expressed the Simian virus-40 large T antigen and presented an hyperdiploid-aneuploid karyotype with a modal chromosome number of 64.5. The SZ95 cell line exhibited epithelial, polymorphous characteristics with different cell sizes of up to 3.25-fold during proliferation and 6-fold at confluence, showing numerous cytoplasmic lipid droplets. The cells showed large cytoplasm profiles with abundant organelles, including vacuoles and myelin figures which indicated lipid synthesis, Lack of or only few desmosomal areas were observed, SZ95 cells expressed molecules typically associated with human sebocytes, such as keratins 7, 13, and 19, and several proteins of the polymorphous epithelial mucin family, Functional studies revealed synthesis of the sebaceous lipids squalene and wax esters as well as of triglycerides and free fatty acids, even after 25-40 passages; active lipid secretion; population doubling times of 52.4 +/- 1.6 h; reduced growth but maintenance of lipid synthesis under serum-free conditions; and retrieval of cell proliferation after addition of 5 alpha-dihydrotestosterone, Retinoids significantly inhibited proliferation of certain SZ95 cell clones in the expected magnitude 13-cis-retinoic acid > au-tuans-retinoic acid>>acitretin, Thus SZ95 is an immortalized human sebaceous gland cell line that shows the morphologic, phenotypic and functional characteristics of normal human sebocytes.
引用
收藏
页码:1011 / 1020
页数:10
相关论文
共 61 条
[41]  
Pochi P., 1985, MODELS DERMATOLOGY, V2, P70
[42]   TISSUE DISTRIBUTION OF KERATIN-7 AS MONITORED BY A MONOCLONAL-ANTIBODY [J].
RAMAEKERS, F ;
HUYSMANS, A ;
SCHAART, G ;
MOESKER, O ;
VOOIJS, P .
EXPERIMENTAL CELL RESEARCH, 1987, 170 (01) :235-249
[43]  
SHAPIRO SS, 1989, PHARM RETINOIDS SKIN, V3, P104
[44]   METABOLISM OF ANDROGENS INVITRO BY HUMAN FETAL SKIN [J].
SHARP, F ;
HAY, JB ;
HODGINS, MB .
JOURNAL OF ENDOCRINOLOGY, 1976, 70 (03) :491-499
[45]   HIGH-EFFICIENCY TRANSFECTION OF PRIMARY HUMAN KERATINOCYTES WITH POSITIVELY CHARGED LIPOPOLYAMINE-DNA COMPLEXES [J].
STAEDEL, C ;
REMY, JS ;
HUA, ZX ;
BROKER, TR ;
CHOW, LT ;
BEHR, JP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (05) :768-772
[46]  
STAHLI C, 1988, CANCER RES, V48, P6799
[47]   Sebaceous gland, acne and related disorders - An epilogue [J].
Strauss, JS .
DERMATOLOGY, 1998, 196 (01) :182-184
[48]   MONOCLONAL-ANTIBODIES TO EPITHELIUM-SPECIFIC COMPONENTS OF THE HUMAN-MILK FAT GLOBULE-MEMBRANE - PRODUCTION AND REACTION WITH CELLS IN CULTURE [J].
TAYLORPAPADIMITRIOU, J ;
PETERSON, JA ;
ARKLIE, J ;
BURCHELL, J ;
CERIANI, RL ;
BODMER, WF .
INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (01) :17-21
[49]   Characterization of human amniotic epithelial cells transformed with origin-defective SV40 T-antigen gene [J].
Tohyama, J ;
Tsunoda, H ;
Sakuragawa, N .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 182 (01) :75-82
[50]   IMMUNOHISTOCHEMICAL DEMONSTRATION OF MAM-3 AND MAM-6 ANTIGENS IN NORMAL HUMAN-SKIN APPENDAGES AND THEIR TUMORS [J].
TSUBURA, A ;
MORII, S ;
UEDA, S ;
SASAKI, M ;
ZOTTER, S ;
WATZIG, V ;
MOOI, W ;
HAGEMAN, P ;
HILKENS, J ;
VANDENTWEEL, J ;
MEIJER, C ;
HILGERS, J .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1987, 279 (08) :550-557